Interestingly, de novo expression of LSEC FABP4 in response to exposure to glucose, insulin or hypoxia potentiates the oncogenic effects of hepatoma cell lines (HepG2, SKHep1, and Huh7) through activation of mechanistic target of rapamycin (mTOR) pathway. The gene discussed is MTOR; the disease is hepatocellular carcinoma.